|
|
|
Volumn 14, Issue 9, 2005, Pages
|
|
Plans struggle for control of specialty pharma costs.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
BIOTECHNOLOGY;
COST CONTROL;
DRUG COST;
DRUG DESIGN;
DRUG INDUSTRY;
ECONOMICS;
HEALTH CARE DELIVERY;
HEALTH INSURANCE;
HUMAN;
RESEARCH;
UNITED STATES;
BIOTECHNOLOGY;
COST CONTROL;
DRUG COSTS;
DRUG DESIGN;
DRUG INDUSTRY;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
MANAGED CARE PROGRAMS;
RESEARCH;
UNITED STATES;
|
|
EID: 33644874736
PISSN: 10623388
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
